Document is current
Any future updates will be listed below
-
Authors
Vaillend, Cyrille
Aoki, Yoshitsugu https://orcid.org/0000-0002-9038-7506
Mercuri, Eugenio
Hendriksen, Jos
Tetorou, Konstantina
Goyenvalle, Aurelie https://orcid.org/0000-0003-3938-1165
Muntoni, Francesco https://orcid.org/0000-0002-9102-5232
- License Information
-
More Information
Article History
Received: 27 June 2024
Accepted: 20 January 2025
First Online: 3 February 2025
Competing interests
: The authors declare the following competing interests. F.M. has received grants, speaker, and consultancy honoraria from Sarepta Therapeutics, Roche, PTC Therapeutics, Dyne Therapeutics, and Pfizer. E.M. has received grants, speaker, and consultancy honoraria from Sarepta Therapeutics, Roche, Italfarmaco. Y.A. has received grants and consultancy honoraria from Nippon Shinyaku Co., Ltd. and grants from Shionogi & Co., Ltd. C.V., J.H., K.T. and A.G., declare no competing interests.
